Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03484520 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03484520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03484520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Lead sponsor
AbbVie
Phase
Phase 1
Overall status
Terminated
Start date
July 23, 2018
Completion date
December 1, 2022
Enrollment
48 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

cancer - acute myeloid leukemia